SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-321954
Filing Date
2018-11-08
Accepted
2018-11-08 08:20:57
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d637133d10q.htm 10-Q 818826
2 EX-10.1 d637133dex101.htm EX-10.1 247844
3 EX-31.1 d637133dex311.htm EX-31.1 6313
4 EX-31.2 d637133dex312.htm EX-31.2 6301
5 EX-32.1 d637133dex321.htm EX-32.1 4849
  Complete submission text file 0001193125-18-321954.txt   3594283

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mgta-20180930.xml EX-101.INS 383760
7 XBRL TAXONOMY EXTENSION SCHEMA mgta-20180930.xsd EX-101.SCH 37739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20180930_cal.xml EX-101.CAL 50551
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20180930_def.xml EX-101.DEF 247303
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20180930_lab.xml EX-101.LAB 327488
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20180930_pre.xml EX-101.PRE 283720
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 181168280
SIC: 2834 Pharmaceutical Preparations